Cargando…
Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury
Autores principales: | Dixon, Barry, Schultz, Marcus J, Hofstra, Jorrit J, Campbell, Duncan J, Santamaria, John D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219269/ https://www.ncbi.nlm.nih.gov/pubmed/21067553 http://dx.doi.org/10.1186/cc9269 |
Ejemplares similares
-
A phase 1 trial of nebulized heparin in acute lung injury
por: Dixon, B, et al.
Publicado: (2008) -
Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial
por: Dixon, Barry, et al.
Publicado: (2010) -
Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury
por: Hofstra, Jorrit J., et al.
Publicado: (2013) -
A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008) -
Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats
por: Hofstra, Jorrit J, et al.
Publicado: (2009)